img

Global Therapeutic Peptide Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Therapeutic Peptide Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Polypeptide molecules are ideal drug molecules due to their high affinity, high selectivity, low toxicity and easy synthesis.
Therapeutic Peptide report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Therapeutic Peptide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cancer and Metabolic Disorders are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Therapeutic Peptide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Therapeutic Peptide key manufacturers include AbbVie, AstraZeneca, Ipsen, Eli Lilly, Merck, Novo Nordisk, Novartis, Johnson and Johnson and Sanofi, etc. AbbVie, AstraZeneca, Ipsen are top 3 players and held % sales share in total in 2022.
Therapeutic Peptide can be divided into Oral, Injection and Other,, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Therapeutic Peptide is widely used in various fields, such as Cancer, Metabolic Disorders, Central Nervous System and Other, etc. Cancer provides greatest supports to the Therapeutic Peptide industry development. In 2022, global % sales of Therapeutic Peptide went into Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Therapeutic Peptide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie
AstraZeneca
Ipsen
Eli Lilly
Merck
Novo Nordisk
Novartis
Johnson and Johnson
Sanofi
Teva
Takeda
Segment by Type
Oral
Injection
Other

Segment by Application


Cancer
Metabolic Disorders
Central Nervous System
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Therapeutic Peptide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Therapeutic Peptide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Therapeutic Peptide industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Therapeutic Peptide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Therapeutic Peptide introduction, etc. Therapeutic Peptide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Therapeutic Peptide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Therapeutic Peptide Market Overview
1.1 Therapeutic Peptide Product Overview
1.2 Therapeutic Peptide Market Segment by Type
1.2.1 Oral
1.2.2 Injection
1.2.3 Other
1.3 Global Therapeutic Peptide Market Size by Type
1.3.1 Global Therapeutic Peptide Market Size Overview by Type (2024-2034)
1.3.2 Global Therapeutic Peptide Historic Market Size Review by Type (2024-2024)
1.3.3 Global Therapeutic Peptide Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Therapeutic Peptide Sales Breakdown by Type (2024-2024)
1.4.2 Europe Therapeutic Peptide Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Therapeutic Peptide Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Therapeutic Peptide Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Therapeutic Peptide Sales Breakdown by Type (2024-2024)
2 Global Therapeutic Peptide Market Competition by Company
2.1 Global Top Players by Therapeutic Peptide Sales (2024-2024)
2.2 Global Top Players by Therapeutic Peptide Revenue (2024-2024)
2.3 Global Top Players by Therapeutic Peptide Price (2024-2024)
2.4 Global Top Manufacturers Therapeutic Peptide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Therapeutic Peptide Market Competitive Situation and Trends
2.5.1 Therapeutic Peptide Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Therapeutic Peptide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Peptide as of 2022)
2.7 Date of Key Manufacturers Enter into Therapeutic Peptide Market
2.8 Key Manufacturers Therapeutic Peptide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Therapeutic Peptide Status and Outlook by Region
3.1 Global Therapeutic Peptide Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Therapeutic Peptide Historic Market Size by Region
3.2.1 Global Therapeutic Peptide Sales in Volume by Region (2024-2024)
3.2.2 Global Therapeutic Peptide Sales in Value by Region (2024-2024)
3.2.3 Global Therapeutic Peptide Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Therapeutic Peptide Forecasted Market Size by Region
3.3.1 Global Therapeutic Peptide Sales in Volume by Region (2024-2034)
3.3.2 Global Therapeutic Peptide Sales in Value by Region (2024-2034)
3.3.3 Global Therapeutic Peptide Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Therapeutic Peptide by Application
4.1 Therapeutic Peptide Market Segment by Application
4.1.1 Cancer
4.1.2 Metabolic Disorders
4.1.3 Central Nervous System
4.1.4 Other
4.2 Global Therapeutic Peptide Market Size by Application
4.2.1 Global Therapeutic Peptide Market Size Overview by Application (2024-2034)
4.2.2 Global Therapeutic Peptide Historic Market Size Review by Application (2024-2024)
4.2.3 Global Therapeutic Peptide Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Therapeutic Peptide Sales Breakdown by Application (2024-2024)
4.3.2 Europe Therapeutic Peptide Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Therapeutic Peptide Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Therapeutic Peptide Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Therapeutic Peptide Sales Breakdown by Application (2024-2024)
5 North America Therapeutic Peptide by Country
5.1 North America Therapeutic Peptide Historic Market Size by Country
5.1.1 North America Therapeutic Peptide Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Therapeutic Peptide Sales in Volume by Country (2024-2024)
5.1.3 North America Therapeutic Peptide Sales in Value by Country (2024-2024)
5.2 North America Therapeutic Peptide Forecasted Market Size by Country
5.2.1 North America Therapeutic Peptide Sales in Volume by Country (2024-2034)
5.2.2 North America Therapeutic Peptide Sales in Value by Country (2024-2034)
6 Europe Therapeutic Peptide by Country
6.1 Europe Therapeutic Peptide Historic Market Size by Country
6.1.1 Europe Therapeutic Peptide Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Therapeutic Peptide Sales in Volume by Country (2024-2024)
6.1.3 Europe Therapeutic Peptide Sales in Value by Country (2024-2024)
6.2 Europe Therapeutic Peptide Forecasted Market Size by Country
6.2.1 Europe Therapeutic Peptide Sales in Volume by Country (2024-2034)
6.2.2 Europe Therapeutic Peptide Sales in Value by Country (2024-2034)
7 Asia-Pacific Therapeutic Peptide by Region
7.1 Asia-Pacific Therapeutic Peptide Historic Market Size by Region
7.1.1 Asia-Pacific Therapeutic Peptide Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Therapeutic Peptide Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Therapeutic Peptide Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Therapeutic Peptide Forecasted Market Size by Region
7.2.1 Asia-Pacific Therapeutic Peptide Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Therapeutic Peptide Sales in Value by Region (2024-2034)
8 Latin America Therapeutic Peptide by Country
8.1 Latin America Therapeutic Peptide Historic Market Size by Country
8.1.1 Latin America Therapeutic Peptide Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Therapeutic Peptide Sales in Volume by Country (2024-2024)
8.1.3 Latin America Therapeutic Peptide Sales in Value by Country (2024-2024)
8.2 Latin America Therapeutic Peptide Forecasted Market Size by Country
8.2.1 Latin America Therapeutic Peptide Sales in Volume by Country (2024-2034)
8.2.2 Latin America Therapeutic Peptide Sales in Value by Country (2024-2034)
9 Middle East and Africa Therapeutic Peptide by Country
9.1 Middle East and Africa Therapeutic Peptide Historic Market Size by Country
9.1.1 Middle East and Africa Therapeutic Peptide Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Therapeutic Peptide Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Therapeutic Peptide Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Therapeutic Peptide Forecasted Market Size by Country
9.2.1 Middle East and Africa Therapeutic Peptide Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Therapeutic Peptide Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.1.4 AbbVie Therapeutic Peptide Products Offered
10.1.5 AbbVie Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.2.4 AstraZeneca Therapeutic Peptide Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Ipsen
10.3.1 Ipsen Company Information
10.3.2 Ipsen Introduction and Business Overview
10.3.3 Ipsen Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Ipsen Therapeutic Peptide Products Offered
10.3.5 Ipsen Recent Development
10.4 Eli Lilly
10.4.1 Eli Lilly Company Information
10.4.2 Eli Lilly Introduction and Business Overview
10.4.3 Eli Lilly Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Eli Lilly Therapeutic Peptide Products Offered
10.4.5 Eli Lilly Recent Development
10.5 Merck
10.5.1 Merck Company Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Merck Therapeutic Peptide Products Offered
10.5.5 Merck Recent Development
10.6 Novo Nordisk
10.6.1 Novo Nordisk Company Information
10.6.2 Novo Nordisk Introduction and Business Overview
10.6.3 Novo Nordisk Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Novo Nordisk Therapeutic Peptide Products Offered
10.6.5 Novo Nordisk Recent Development
10.7 Novartis
10.7.1 Novartis Company Information
10.7.2 Novartis Introduction and Business Overview
10.7.3 Novartis Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Novartis Therapeutic Peptide Products Offered
10.7.5 Novartis Recent Development
10.8 Johnson and Johnson
10.8.1 Johnson and Johnson Company Information
10.8.2 Johnson and Johnson Introduction and Business Overview
10.8.3 Johnson and Johnson Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Johnson and Johnson Therapeutic Peptide Products Offered
10.8.5 Johnson and Johnson Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Introduction and Business Overview
10.9.3 Sanofi Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Sanofi Therapeutic Peptide Products Offered
10.9.5 Sanofi Recent Development
10.10 Teva
10.10.1 Teva Company Information
10.10.2 Teva Introduction and Business Overview
10.10.3 Teva Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Teva Therapeutic Peptide Products Offered
10.10.5 Teva Recent Development
10.11 Takeda
10.11.1 Takeda Company Information
10.11.2 Takeda Introduction and Business Overview
10.11.3 Takeda Therapeutic Peptide Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Takeda Therapeutic Peptide Products Offered
10.11.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Therapeutic Peptide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Therapeutic Peptide Industrial Chain Analysis
11.4 Therapeutic Peptide Market Dynamics
11.4.1 Therapeutic Peptide Industry Trends
11.4.2 Therapeutic Peptide Market Drivers
11.4.3 Therapeutic Peptide Market Challenges
11.4.4 Therapeutic Peptide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Therapeutic Peptide Distributors
12.3 Therapeutic Peptide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oral
Table 2. Major Company of Injection
Table 3. Major Company of Other
Table 4. Global Therapeutic Peptide Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Therapeutic Peptide Sales by Type (2024-2024) & (K Units)
Table 6. Global Therapeutic Peptide Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Therapeutic Peptide Sales by Type (2024-2024) & (US& Million)
Table 8. Global Therapeutic Peptide Market Share in Value by Type (2024-2024)
Table 9. Global Therapeutic Peptide Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Therapeutic Peptide Sales by Type (2024-2034) & (K Units)
Table 11. Global Therapeutic Peptide Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Therapeutic Peptide Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Therapeutic Peptide Sales Market Share in Value by Type (2024-2034)
Table 14. Global Therapeutic Peptide Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Therapeutic Peptide Sales by Type (2024-2024) & (K Units)
Table 16. North America Therapeutic Peptide Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Therapeutic Peptide Sales (K Units) by Type (2024-2024)
Table 18. Europe Therapeutic Peptide Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Therapeutic Peptide Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Therapeutic Peptide Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Therapeutic Peptide Sales (K Units) by Type (2024-2024)
Table 22. Latin America Therapeutic Peptide Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Therapeutic Peptide Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Therapeutic Peptide Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Therapeutic Peptide Sales by Company (2024-2024) & (K Units)
Table 26. Global Therapeutic Peptide Sales Share by Company (2024-2024)
Table 27. Global Therapeutic Peptide Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Therapeutic Peptide Revenue Share by Company (2024-2024)
Table 29. Global Market Therapeutic Peptide Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Therapeutic Peptide Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Therapeutic Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Peptide as of 2022)
Table 33. Date of Key Manufacturers Enter into Therapeutic Peptide Market
Table 34. Key Manufacturers Therapeutic Peptide Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Therapeutic Peptide Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Therapeutic Peptide Sales by Region (2024-2024) & (K Units)
Table 38. Global Therapeutic Peptide Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Therapeutic Peptide Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Therapeutic Peptide Sales Market Share in Value by Region (2024-2024)
Table 41. Global Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Therapeutic Peptide Sales by Region (2024-2034) & (K Units)
Table 43. Global Therapeutic Peptide Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Therapeutic Peptide Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Therapeutic Peptide Sales Market Share in Value by Region (2024-2034)
Table 46. Global Therapeutic Peptide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Therapeutic Peptide Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Therapeutic Peptide Sales by Application (2024-2024) & (K Units)
Table 49. Global Therapeutic Peptide Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Therapeutic Peptide Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Therapeutic Peptide Sales Market Share in Value by Application (2024-2024)
Table 52. Global Therapeutic Peptide Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Therapeutic Peptide Sales by Application (2024-2034) & (K Units)
Table 54. Global Therapeutic Peptide Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Therapeutic Peptide Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Therapeutic Peptide Sales Market Share in Value by Application (2024-2034)
Table 57. Global Therapeutic Peptide Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Therapeutic Peptide Sales by Application (2024-2024) (K Units)
Table 59. North America Therapeutic Peptide Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Therapeutic Peptide Sales by Application (2024-2024) (K Units)
Table 61. Europe Therapeutic Peptide Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Therapeutic Peptide Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Therapeutic Peptide Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Therapeutic Peptide Sales by Application (2024-2024) (K Units)
Table 65. Latin America Therapeutic Peptide Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Therapeutic Peptide Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Therapeutic Peptide Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Therapeutic Peptide Sales by Country (2024-2024) & (K Units)
Table 69. North America Therapeutic Peptide Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Therapeutic Peptide Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Therapeutic Peptide Sales Market Share in Value by Country (2024-2024)
Table 72. North America Therapeutic Peptide Sales by Country (2024-2034) & (K Units)
Table 73. North America Therapeutic Peptide Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Therapeutic Peptide Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Therapeutic Peptide Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Therapeutic Peptide Sales by Country (2024-2024) & (K Units)
Table 77. Europe Therapeutic Peptide Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Therapeutic Peptide Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Therapeutic Peptide Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Therapeutic Peptide Sales by Country (2024-2034) & (K Units)
Table 81. Europe Therapeutic Peptide Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Therapeutic Peptide Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Therapeutic Peptide Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Therapeutic Peptide Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Therapeutic Peptide Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Therapeutic Peptide Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Therapeutic Peptide Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Therapeutic Peptide Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Therapeutic Peptide Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Therapeutic Peptide Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Therapeutic Peptide Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Therapeutic Peptide Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Therapeutic Peptide Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Therapeutic Peptide Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Therapeutic Peptide Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Therapeutic Peptide Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Therapeutic Peptide Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Therapeutic Peptide Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Therapeutic Peptide Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Therapeutic Peptide Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Therapeutic Peptide Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Therapeutic Peptide Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Therapeutic Peptide Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Therapeutic Peptide Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Therapeutic Peptide Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Therapeutic Peptide Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Therapeutic Peptide Sales Market Share in Value by Country (2024-2034)
Table 108. AbbVie Company Information
Table 109. AbbVie Introduction and Business Overview
Table 110. AbbVie Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. AbbVie Therapeutic Peptide Product
Table 112. AbbVie Recent Development
Table 113. AstraZeneca Company Information
Table 114. AstraZeneca Introduction and Business Overview
Table 115. AstraZeneca Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. AstraZeneca Therapeutic Peptide Product
Table 117. AstraZeneca Recent Development
Table 118. Ipsen Company Information
Table 119. Ipsen Introduction and Business Overview
Table 120. Ipsen Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Ipsen Therapeutic Peptide Product
Table 122. Ipsen Recent Development
Table 123. Eli Lilly Company Information
Table 124. Eli Lilly Introduction and Business Overview
Table 125. Eli Lilly Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Eli Lilly Therapeutic Peptide Product
Table 127. Eli Lilly Recent Development
Table 128. Merck Company Information
Table 129. Merck Introduction and Business Overview
Table 130. Merck Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Merck Therapeutic Peptide Product
Table 132. Merck Recent Development
Table 133. Novo Nordisk Company Information
Table 134. Novo Nordisk Introduction and Business Overview
Table 135. Novo Nordisk Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Novo Nordisk Therapeutic Peptide Product
Table 137. Novo Nordisk Recent Development
Table 138. Novartis Company Information
Table 139. Novartis Introduction and Business Overview
Table 140. Novartis Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Novartis Therapeutic Peptide Product
Table 142. Novartis Recent Development
Table 143. Johnson and Johnson Company Information
Table 144. Johnson and Johnson Introduction and Business Overview
Table 145. Johnson and Johnson Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 146. Johnson and Johnson Therapeutic Peptide Product
Table 147. Johnson and Johnson Recent Development
Table 148. Sanofi Company Information
Table 149. Sanofi Introduction and Business Overview
Table 150. Sanofi Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 151. Sanofi Therapeutic Peptide Product
Table 152. Sanofi Recent Development
Table 153. Teva Company Information
Table 154. Teva Introduction and Business Overview
Table 155. Teva Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 156. Teva Therapeutic Peptide Product
Table 157. Teva Recent Development
Table 158. Takeda Company Information
Table 159. Takeda Introduction and Business Overview
Table 160. Takeda Therapeutic Peptide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 161. Takeda Therapeutic Peptide Product
Table 162. Takeda Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Therapeutic Peptide Market Trends
Table 166. Therapeutic Peptide Market Drivers
Table 167. Therapeutic Peptide Market Challenges
Table 168. Therapeutic Peptide Market Restraints
Table 169. Therapeutic Peptide Distributors List
Table 170. Therapeutic Peptide Downstream Customers
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Peptide Product Picture
Figure 2. Global Therapeutic Peptide Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Therapeutic Peptide Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Therapeutic Peptide Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Oral
Figure 6. Global Oral Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Injection
Figure 8. Global Injection Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Other
Figure 10. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Therapeutic Peptide Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Therapeutic Peptide Sales Market Share by Type in 2022 & 2034
Figure 13. North America Therapeutic Peptide Sales Market Share in Volume by Type in 2022
Figure 14. North America Therapeutic Peptide Sales Market Share in Value by Type in 2022
Figure 15. Europe Therapeutic Peptide Sales Market Share in Volume by Type in 2022
Figure 16. Europe Therapeutic Peptide Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Therapeutic Peptide Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Therapeutic Peptide Sales Market Share in Value by Type in 2022
Figure 19. Latin America Therapeutic Peptide Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Therapeutic Peptide Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Therapeutic Peptide Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Therapeutic Peptide Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Therapeutic Peptide Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Therapeutic Peptide Revenue in 2022
Figure 25. Therapeutic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Cancer
Figure 27. Global Cancer Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Metabolic Disorders
Figure 29. Global Metabolic Disorders Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Central Nervous System
Figure 31. Global Central Nervous System Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Therapeutic Peptide Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Therapeutic Peptide Sales Market Share by Application in 2022 & 2034
Figure 36. North America Therapeutic Peptide Sales Market Share in Volume by Application in 2022
Figure 37. North America Therapeutic Peptide Sales Market Share in Value by Application in 2022
Figure 38. Europe Therapeutic Peptide Sales Market Share in Volume by Application in 2022
Figure 39. Europe Therapeutic Peptide Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Therapeutic Peptide Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Therapeutic Peptide Sales Market Share in Value by Application in 2022
Figure 42. Latin America Therapeutic Peptide Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Therapeutic Peptide Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Therapeutic Peptide Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Therapeutic Peptide Manufacturing Cost Structure
Figure 47. Therapeutic Peptide Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries